StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
Adolor Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of prescription pain management products. Its product includes ENTEREG (alvimopan), a small molecule peripherally-acting mu-opioid receptor antagonist designed to block the adverse side effects of opioid analgesics on the gastrointestinal tract, as well as for the management of postoperative ileus following bowel resection surgery that causes significant discomfort for patients.
About StockEinstein
StockEinstein.com
uses proprietary technologies coupled with years of experience to
uncover stocks we feel have the greatest potential for breakout
performance. We utilize not only software, but time tested criteria to
uncover these potential winners. When these benchmarks are reached or
exceeded, our subscribers are immediately notified.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT:
Never invest in any stock featured in any press release, email or
website unless you can afford the loss of your entire investment.
Stocks and particularly penny stocks have the possibility for dramatic
gains, and also losses. Neither StockEinstein, nor any of its
affiliates are registered investment advisors or broker dealers.
Thank you for your interest in Findit News. A member of the Findit News team will contact you soon to show you how you can take your marketing to the next level with press releases on Findit.
